As we age, our bodies change, and our eyes are no exception. The good news is that with regular checks and a healthy lifestyle, most people can maintain ...

The Philadelphia 76ers returned home on Tuesday to play host to the San Antonio Spurs looking to get back in the win column ...

Despite a significant drop in quarterly revenue, EyePoint Inc (EYPT) focuses on advancing DURAVYU's clinical trials and preparing for a potential US launch.

Eyepoint Pharmaceuticals (NASDAQ:EYPT) outlined late-stage clinical progress for its lead retinal candidate DURAVYU and ...

Duker indicated that EyePoint expects to report top line data for the Phase III LUGANO trial in mid-2026 with LUCIA data to follow closely, complete enrollment in the pivotal Phase III DME program in ...